Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership
Airtripmaker Expands Business and First-class Flights Network to London, Amsterdam, Frankfurt, Tokyo, Sydney by Introducing Enhanced Coverage for Global Destinations as Part of Its Ongoing Growth Strategy
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
TORONTO–(BUSINESS WIRE)–$STEEF #Technology–STEER Technologies Inc. (“STEER” or the “Company”) (TSXV: STER) (OTCQX: STEEF), an integrated…
– Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous…
FAIRFAX, Va.–(BUSINESS WIRE)–Fairfax-based FVCbank has been honored by Keefe, Bruyette & Woods, Inc. (KBW) by…
Edifecs executives lead conversations on interoperability, health equity, and prior authorization BELLEVUE, Wash.–(BUSINESS WIRE)–Edifecs, Inc.,…
DALLAS–(BUSINESS WIRE)–Today CyrusOne announces that Chief Financial Officer Katherine Motlagh will step down from her…
Toyota City, Japan, May 19, 2023 – (JCN Newswire) – It has been discovered that…
NEW YORK–(BUSINESS WIRE)–KKR, a leading global investment firm, today announced it has named Dan Pietrzak…
Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently…
Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently…
New OTL-203 proof-of-concept data demonstrate extensive metabolic correction in the skeletal system of patients with…
New OTL-203 proof-of-concept data demonstrate extensive metabolic correction in the skeletal system of patients with…
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Treatment with CAN-3110 in arm A showed encouraging median overall survival rate at 11.8 months…
Treatment with CAN-3110 in arm A showed encouraging median overall survival rate at 11.8 months…
New preclinical data after neonatal administration in wild-type mice showed no detectable impact on survival,…
New preclinical data after neonatal administration in wild-type mice showed no detectable impact on survival,…
MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics, a biotechnology…
MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics, a biotechnology…